These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 12358254)

  • 1. Perinuclear neutrophil antibodies are not markers for genetic susceptibility or indicators of genetic heterogeneity in familial ulcerative colitis.
    Achkar JP; Barmada MM; Duerr RH
    Am J Gastroenterol; 2002 Sep; 97(9):2343-9. PubMed ID: 12358254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of antineutrophil cytoplasmic antibodies in an ethnically distinct population: Korean patients with ulcerative colitis.
    Kim WH; Choi PM; Landers CJ; Targan SR
    Am J Gastroenterol; 1995 Nov; 90(11):1953-8. PubMed ID: 7484998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features in familial cases of Crohn's disease and ulcerative colitis in Italy: a GISC study. Italian Study Group for the Disease of Colon and Rectum.
    Annese V; Andreoli A; Astegiano M; Campieri M; Caprilli R; Cucchiara S; D'Incà R; Giaccari S; Iaquinto G; Lombardi G; Napolitano G; Pera A; Riegler G; Valpiani D; Andriulli A;
    Am J Gastroenterol; 2001 Oct; 96(10):2939-45. PubMed ID: 11693330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers.
    Yang H; Rotter JI; Toyoda H; Landers C; Tyran D; McElree CK; Targan SR
    J Clin Invest; 1993 Aug; 92(2):1080-4. PubMed ID: 8349790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting a change in diagnosis from ulcerative colitis to Crohn's disease: a nested, case-control study.
    Melmed GY; Elashoff R; Chen GC; Nastaskin I; Papadakis KA; Vasiliauskas EA; Liu W; Landers C; Ippoliti AF; Targan SR
    Clin Gastroenterol Hepatol; 2007 May; 5(5):602-8; quiz 525. PubMed ID: 17478347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet.
    Granito A; Zauli D; Muratori P; Muratori L; Grassi A; Bortolotti R; Petrolini N; Veronesi L; Gionchetti P; Bianchi FB; Volta U
    Aliment Pharmacol Ther; 2005 Apr; 21(7):881-7. PubMed ID: 15801923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal calprotectin in first-degree relatives of patients with ulcerative colitis.
    Montalto M; Curigliano V; Santoro L; Armuzzi A; Cammarota G; Covino M; Mentella MC; Ancarani F; Manna R; Gasbarrini A; Gasbarrini G
    Am J Gastroenterol; 2007 Jan; 102(1):132-6. PubMed ID: 17100982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
    Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
    Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn's disease.
    Mei L; Targan SR; Landers CJ; Dutridge D; Ippoliti A; Vasiliauskas EA; Papadakis KA; Fleshner PR; Rotter JI; Yang H
    Gastroenterology; 2006 Apr; 130(4):1078-85. PubMed ID: 16618402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis.
    Davis MK; Andres JM; Jolley CD; Novak DA; Haafiz AB; González-Peralta RP
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):409-13. PubMed ID: 18030205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and significance of perinuclear anti-neutrophil antibodies (pANCA) in Romanian patients with Crohn's disease and ulcerative colitis.
    Preda CM; Vermeire S; Rutgeerts P; Joosens S; Diculescu M; Marica C; Ciocarlan M; Mirea V; Oproiu A
    Rom J Gastroenterol; 2005 Dec; 14(4):357-60. PubMed ID: 16400351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
    Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA-bound lactoferrin is the major target for antineutrophil perinuclear cytoplasmic antibodies in ulcerative colitis.
    Teegen B; Niemann S; Probst C; Schlumberger W; Stöcker W; Komorowski L
    Ann N Y Acad Sci; 2009 Sep; 1173():161-5. PubMed ID: 19758145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA antigens and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease.
    García Herola A; Nos P; Hinijosa J; Hoyos M; Molés JR; Carmona E; Puig N; Sánchez-Cuenca JM; Ponce J; Berenguer J
    Rev Esp Enferm Dig; 2003 Nov; 95(11):760-4, 755-9. PubMed ID: 14640873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity.
    Shanahan F; Duerr RH; Rotter JI; Yang H; Sutherland LR; McElree C; Landers CJ; Targan SR
    Gastroenterology; 1992 Aug; 103(2):456-61. PubMed ID: 1634063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for association of OCTN genes and IBD5 with ulcerative colitis.
    Waller S; Tremelling M; Bredin F; Godfrey L; Howson J; Parkes M
    Gut; 2006 Jun; 55(6):809-14. PubMed ID: 16361305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
    Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
    Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic heterogeneity in ulcerative colitis.
    Lashner BA
    Am J Gastroenterol; 1994 Nov; 89(11):1927-8. PubMed ID: 7942713
    [No Abstract]   [Full Text] [Related]  

  • 20. Promoter polymorphism of cyclooxygenase-1 (COX1) is not associated with ulcerative colitis in the Japanese population.
    Arisawa T; Tahara T; Shibata T; Nagasaka M; Nakamura M; Kamiya Y; Fujita H; Yoshioka D; Okubo M; Sakata M; Wang FY; Hirata I; Nakano H
    Hepatogastroenterology; 2008; 55(84):987-90. PubMed ID: 18705313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.